Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ariane Boumendil

Showing results (71-80 of 103) with videos related to

Pageof 11
Sort By:
Critical Care (London, England)|September 24, 2021
Differences in mortality in critically ill elderly patients during the second COVID-19 surge in EuropeChristian Jung, Jesper Fjølner, Raphael Romano Bruno, et al.
Blood Advances|December 3, 2021
Outcome of allogeneic transplantation for mature T-cell lymphomas: impact of donor source and disease characteristicsMehdi Hamadani, Maud Ngoya, Anna Sureda, et al.
Cancer|October 24, 2018
Brentuximab vedotin for recurrent Hodgkin lymphoma after allogeneic hematopoietic stem cell transplantation: A report from the EBMT Lymphoma Working PartyAli Bazarbachi, Ariane Boumendil, Hervé Finel, et al.
BMJ Open|June 4, 2021
Provision of critical care for the elderly in Europe: a retrospective comparison of national healthcare frameworks in intensive care unitsBernhard Wernly, Michael Beil, Raphael Romano Bruno, et al.
Scientific Reports|October 19, 2022
A retrospective cohort study comparing differences in 30-day mortality among critically ill patients aged ≥ 70 years treated in European tax-based healthcare systems (THS) versus social health insurance systemsBernhard Wernly, Hans Flaatten, Michael Beil, et al.
British Journal of Haematology|September 10, 2019
Influence of donor type, stem cell source and conditioning on outcomes after haploidentical transplant for lymphoma - a LWP-EBMT studyAli Bazarbachi, Ariane Boumendil, Hervé Finel, et al.
Journal of the American Geriatrics Society|April 13, 2019
Cumulative Prognostic Score Predicting Mortality in Patients Older Than 80 Years Admitted to the ICUDylan W de Lange, Sylvia Brinkman, Hans Flaatten, et al.
Journal of Internal Medicine|April 10, 2022
Variations in end-of-life care practices in older critically ill patients with COVID-19 in EuropeBernhard Wernly, Richard Rezar, Hans Flaatten, et al.
Blood Advances|February 7, 2019
PTCy-based haploidentical vs matched related or unrelated donor reduced-intensity conditioning transplant for DLBCLPeter Dreger, Anna Sureda, Kwang Woo Ahn, et al.
British Journal of Haematology|July 10, 2018
High-dose therapy and autologous stem cell transplantation in marginal zone lymphomas: a retrospective study by the EBMT Lymphoma Working Party and FIL-GITMOIrit Avivi, Luca Arcaini, Virginia V Ferretti, et al.
Pageof 11

Showing results (71-80 of 103) with videos related to

Sort By:
Pageof 11
Critical Care (London, England)|September 24, 2021
Differences in mortality in critically ill elderly patients during the second COVID-19 surge in EuropeChristian Jung, Jesper Fjølner, Raphael Romano Bruno, et al.
Blood Advances|December 3, 2021
Outcome of allogeneic transplantation for mature T-cell lymphomas: impact of donor source and disease characteristicsMehdi Hamadani, Maud Ngoya, Anna Sureda, et al.
Cancer|October 24, 2018
Brentuximab vedotin for recurrent Hodgkin lymphoma after allogeneic hematopoietic stem cell transplantation: A report from the EBMT Lymphoma Working PartyAli Bazarbachi, Ariane Boumendil, Hervé Finel, et al.
BMJ Open|June 4, 2021
Provision of critical care for the elderly in Europe: a retrospective comparison of national healthcare frameworks in intensive care unitsBernhard Wernly, Michael Beil, Raphael Romano Bruno, et al.
Scientific Reports|October 19, 2022
A retrospective cohort study comparing differences in 30-day mortality among critically ill patients aged ≥ 70 years treated in European tax-based healthcare systems (THS) versus social health insurance systemsBernhard Wernly, Hans Flaatten, Michael Beil, et al.
British Journal of Haematology|September 10, 2019
Influence of donor type, stem cell source and conditioning on outcomes after haploidentical transplant for lymphoma - a LWP-EBMT studyAli Bazarbachi, Ariane Boumendil, Hervé Finel, et al.
Journal of the American Geriatrics Society|April 13, 2019
Cumulative Prognostic Score Predicting Mortality in Patients Older Than 80 Years Admitted to the ICUDylan W de Lange, Sylvia Brinkman, Hans Flaatten, et al.
Journal of Internal Medicine|April 10, 2022
Variations in end-of-life care practices in older critically ill patients with COVID-19 in EuropeBernhard Wernly, Richard Rezar, Hans Flaatten, et al.
Blood Advances|February 7, 2019
PTCy-based haploidentical vs matched related or unrelated donor reduced-intensity conditioning transplant for DLBCLPeter Dreger, Anna Sureda, Kwang Woo Ahn, et al.
British Journal of Haematology|July 10, 2018
High-dose therapy and autologous stem cell transplantation in marginal zone lymphomas: a retrospective study by the EBMT Lymphoma Working Party and FIL-GITMOIrit Avivi, Luca Arcaini, Virginia V Ferretti, et al.
Pageof 11